Skip to main content
Top
Published in: World Journal of Pediatrics 3/2018

01-06-2018 | Original Article

Serum proteomic profiling for autism using magnetic bead-assisted matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a pilot study

Authors: Yan-Ni Chen, Hui-Ying Du, Zhuo-Yue Shi, Li He, Yu-Ying He, Duan Wang

Published in: World Journal of Pediatrics | Issue 3/2018

Login to get access

Abstract

Background

The pathogenesis of autism spectrum disorders remains elusive and currently there are no diagnostic or predictive biomarkers in autism available. Proteomic profiling has been used in a wide range of neurodevelopmental disorder studies, which could produce deeper perceptions of the molecular bases behind certain disease and potentially becomes useful in discovering biomarkers in autism spectrum disorders.

Methods

Serum samples were collected from autistic children about 3 years old in age (n = 32) and healthy controls (n = 20) in similar age and gender. The samples were identified specific proteins that are differentially expressed by magnetic bead-based pre-fractionation and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-ToF-MS).

Results

Eight protein peaks were significantly different in autistic children from the healthy controls (P < 0.0001). The two peaks with the most significant differences were 6428 and 7758 Da in size.

Conclusion

According to differences in serum protein profiles between the autistic children and healthy controls, this study identified a set of differentially expressed proteins those are significant for further evaluation and might function as biomarkers in autism.
Literature
1.
go back to reference Veenstra-Vanderweele J, Christian SL, Cook EH Jr. Autism as a paradigmatic complex genetic disorder. Annu Rev Genom Hum Genet. 2004;5:379–405.CrossRef Veenstra-Vanderweele J, Christian SL, Cook EH Jr. Autism as a paradigmatic complex genetic disorder. Annu Rev Genom Hum Genet. 2004;5:379–405.CrossRef
2.
go back to reference Bertoglio K, Hendren RL. New developments in autism. Psychiatr Clin N Am. 2009;32:1–14.CrossRef Bertoglio K, Hendren RL. New developments in autism. Psychiatr Clin N Am. 2009;32:1–14.CrossRef
3.
go back to reference Kim YS, Leventhal BL, Koh Y, Fombonne E, Laska E, Lim E, et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011;168:904–12.CrossRefPubMed Kim YS, Leventhal BL, Koh Y, Fombonne E, Laska E, Lim E, et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011;168:904–12.CrossRefPubMed
6.
go back to reference Ozonoff S, Iosif AM, Baguio F, Cook IC, Hill MM, Hutman T, et al. A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry. 2010;49:256–66.PubMedPubMedCentral Ozonoff S, Iosif AM, Baguio F, Cook IC, Hill MM, Hutman T, et al. A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry. 2010;49:256–66.PubMedPubMedCentral
7.
go back to reference Levin Y, Wang L, Ingudomnukul E, Schwarz E, Baron-Cohen S, Palotás A, et al. Real-time evaluation of experimental variation in large-scale LC–MS/MS-based quantitative proteomics of complex samples. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877:1299–305.CrossRef Levin Y, Wang L, Ingudomnukul E, Schwarz E, Baron-Cohen S, Palotás A, et al. Real-time evaluation of experimental variation in large-scale LC–MS/MS-based quantitative proteomics of complex samples. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877:1299–305.CrossRef
8.
go back to reference Petricoin EF, Liotta LA. Mass spectrometry-based diagnostics: the upcoming revolution in disease detection. Clin Chem. 2003;49:533–4.CrossRefPubMed Petricoin EF, Liotta LA. Mass spectrometry-based diagnostics: the upcoming revolution in disease detection. Clin Chem. 2003;49:533–4.CrossRefPubMed
9.
go back to reference Ngounou Wetie AG, Dekroon RM, Mocanu M, Ryan JP, Darie CC, Woods AG. Mass spectrometry for the study of autism and neurodevelopmental disorders. Adv Exp Med Biol. 2014;806:525–44.CrossRefPubMed Ngounou Wetie AG, Dekroon RM, Mocanu M, Ryan JP, Darie CC, Woods AG. Mass spectrometry for the study of autism and neurodevelopmental disorders. Adv Exp Med Biol. 2014;806:525–44.CrossRefPubMed
10.
go back to reference Dudley E, Hässler F, Thome J. Profiling for novel proteomics biomarkers in neurodevelopmental disorders. Expert Rev Proteom. 2011;8:127–36.CrossRef Dudley E, Hässler F, Thome J. Profiling for novel proteomics biomarkers in neurodevelopmental disorders. Expert Rev Proteom. 2011;8:127–36.CrossRef
11.
go back to reference Yang J, Yang SY, Hu XY, Huo SF, Shang WL, Li ZF, et al. Serum peptidome profiling in patients with lung cancer. Anat Rec (Hoboken). 2010;293:2027–33.CrossRef Yang J, Yang SY, Hu XY, Huo SF, Shang WL, Li ZF, et al. Serum peptidome profiling in patients with lung cancer. Anat Rec (Hoboken). 2010;293:2027–33.CrossRef
12.
go back to reference Diamandis EP. Peptidomics for cancer diagnosis: present and future. J Proteome Res. 2006;5:2079–82.CrossRefPubMed Diamandis EP. Peptidomics for cancer diagnosis: present and future. J Proteome Res. 2006;5:2079–82.CrossRefPubMed
13.
14.
go back to reference Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Investig. 2006;116:271–84.CrossRefPubMedPubMedCentral Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Investig. 2006;116:271–84.CrossRefPubMedPubMedCentral
15.
go back to reference Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, et al. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res. 2007;6:4549–55.CrossRefPubMed Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, et al. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res. 2007;6:4549–55.CrossRefPubMed
16.
go back to reference Krueger KE, Srivastava S. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteom. 2006;5:1799–810.CrossRef Krueger KE, Srivastava S. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteom. 2006;5:1799–810.CrossRef
17.
go back to reference Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem. 2007;53:421–8.CrossRefPubMed Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem. 2007;53:421–8.CrossRefPubMed
18.
go back to reference Schaub NP, Jones KJ, Nyalwidhe JO, Cazares LH, Karbassi ID, Semmes OJ, et al. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg. 2009;208:970–8 (discussion 978–980).CrossRefPubMed Schaub NP, Jones KJ, Nyalwidhe JO, Cazares LH, Karbassi ID, Semmes OJ, et al. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg. 2009;208:970–8 (discussion 978–980).CrossRefPubMed
19.
go back to reference Schwamborn K, Krieg RC, Grosse J, Reulen N, Weiskirchen R, Knuechel R, et al. Serum proteomic profiling in patients with bladder cancer. Eur Urol. 2009;56:989–96.CrossRefPubMed Schwamborn K, Krieg RC, Grosse J, Reulen N, Weiskirchen R, Knuechel R, et al. Serum proteomic profiling in patients with bladder cancer. Eur Urol. 2009;56:989–96.CrossRefPubMed
20.
go back to reference Bailey AR, Giunta BN, Obregon D, Nikolic WV, Tian J, Sanberg CD, et al. Peripheral biomarkers in autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int J Clin Exp Med. 2008;1:338–44.PubMedPubMedCentral Bailey AR, Giunta BN, Obregon D, Nikolic WV, Tian J, Sanberg CD, et al. Peripheral biomarkers in autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int J Clin Exp Med. 2008;1:338–44.PubMedPubMedCentral
21.
go back to reference Momeni N, Bergquist J, Brudin L, Behnia F, Sivberg B, Joghataei MT, et al. A novel blood-based biomarker for detection of autism spectrum disorders. Transl Psychiatry. 2012;2:e91.CrossRefPubMedPubMedCentral Momeni N, Bergquist J, Brudin L, Behnia F, Sivberg B, Joghataei MT, et al. A novel blood-based biomarker for detection of autism spectrum disorders. Transl Psychiatry. 2012;2:e91.CrossRefPubMedPubMedCentral
22.
go back to reference Taurines R, Dudley E, Conner AC, Grassl J, Jans T, Guderian F, et al. Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur Arch Psychiatry Clin Neurosci. 2010;260:249–55.CrossRefPubMed Taurines R, Dudley E, Conner AC, Grassl J, Jans T, Guderian F, et al. Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur Arch Psychiatry Clin Neurosci. 2010;260:249–55.CrossRefPubMed
23.
go back to reference Ramsey JM, Guest PC, Broek JA, Glennon JC, Rommelse N, Franke B, et al. Identification of an age-dependent biomarker signature in children and adolescents with autism spectrum disorders. Mol Autism. 2013;4:27.CrossRefPubMedPubMedCentral Ramsey JM, Guest PC, Broek JA, Glennon JC, Rommelse N, Franke B, et al. Identification of an age-dependent biomarker signature in children and adolescents with autism spectrum disorders. Mol Autism. 2013;4:27.CrossRefPubMedPubMedCentral
24.
go back to reference Steeb H, Ramsey JM, Guest PC, Stocki P, Cooper JD, Rahmoune H, et al. Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome. Mol Autism. 2014;5:4.CrossRefPubMedPubMedCentral Steeb H, Ramsey JM, Guest PC, Stocki P, Cooper JD, Rahmoune H, et al. Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome. Mol Autism. 2014;5:4.CrossRefPubMedPubMedCentral
25.
go back to reference Schwarz E, Guest PC, Rahmoune H, Wang L, Levin Y, Ingudomnukul E, et al. Sex-specific serum biomarker patterns in adults with Asperger’s syndrome. Mol Psychiatry. 2011;16:1213–20.CrossRefPubMed Schwarz E, Guest PC, Rahmoune H, Wang L, Levin Y, Ingudomnukul E, et al. Sex-specific serum biomarker patterns in adults with Asperger’s syndrome. Mol Psychiatry. 2011;16:1213–20.CrossRefPubMed
Metadata
Title
Serum proteomic profiling for autism using magnetic bead-assisted matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a pilot study
Authors
Yan-Ni Chen
Hui-Ying Du
Zhuo-Yue Shi
Li He
Yu-Ying He
Duan Wang
Publication date
01-06-2018
Publisher
Childrens Hospital, Zhejiang University School of Medicine
Published in
World Journal of Pediatrics / Issue 3/2018
Print ISSN: 1708-8569
Electronic ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-017-0102-x

Other articles of this Issue 3/2018

World Journal of Pediatrics 3/2018 Go to the issue